• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胶质瘤患者的临床结局在性别之间是否存在差异?

Do clinical outcomes in individuals with malignant gliomas differ between sexes?

作者信息

Goldberg Maria, Frank Laura-Sophie, Altawalbeh Ghaith, Negwer Chiara, Wagner Arthur, Gempt Jens, Meyer Bernhard, Aftahy Amir Kaywan

机构信息

Department of Neurosurgery, School of Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

School of Medicine, Technical University Munich, Munich, Germany.

出版信息

Brain Spine. 2024 Dec 24;5:104172. doi: 10.1016/j.bas.2024.104172. eCollection 2025.

DOI:10.1016/j.bas.2024.104172
PMID:39834719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11743585/
Abstract

INTRODUCTION

Sex-related differences in the epidemiology of malignant gliomas are acknowledged; however, information regarding their clinical characteristics and outcomes after surgery is limited.

RESEARCH QUESTION

To identify sex-specific differences of all patients with high-grade glioma at our institution and assessed clinical outcomes and prognostic factors.

MATERIAL AND METHODS

This single-center study included those who underwent surgery for malignant gliomas between 2010 and 2020. Categorical, normally distributed, and skewed continuous variables were compared between men and women using the chi-square test, independent samples -test, and Mann-Whitney test, respectively. Survival was calculated using the log-rank and Kaplan-Meier methods.

RESULTS

In total, 621 patients with WHO grade IV gliomas were identified (370 (59.58%) male). Men were significantly younger, underwent surgery faster after imaging diagnosis, and had a slightly higher surgical complications incidence than women. Women reported a worse preoperative performance status. Multivariate analysis showed that sex did not affect survival, surgical complications, nicotine or alcohol abuse, or preoperative tumor volume. Age, Karnofsky performance status, neurosurgical resection, and adjuvant radiotherapy with temozolomide showed a survival advantage.

DISCUSSION AND CONCLUSIONS

Men are diagnosed with malignant glioma at a younger age than women; however, no advantage in clinical outcomes was observed. No sex-related differences were observed.

摘要

引言

恶性胶质瘤流行病学中的性别差异已得到公认;然而,关于其临床特征及术后结果的信息有限。

研究问题

确定我院所有高级别胶质瘤患者的性别特异性差异,并评估临床结果和预后因素。

材料与方法

这项单中心研究纳入了2010年至2020年间接受恶性胶质瘤手术的患者。分别使用卡方检验、独立样本t检验和曼-惠特尼U检验对男性和女性之间的分类变量、正态分布变量和偏态连续变量进行比较。使用对数秩检验和Kaplan-Meier方法计算生存率。

结果

共确定621例世界卫生组织IV级胶质瘤患者(370例(59.58%)为男性)。男性明显更年轻,影像学诊断后手术时间更快,手术并发症发生率略高于女性。女性术前功能状态较差。多因素分析显示,性别不影响生存率、手术并发症、尼古丁或酒精滥用情况或术前肿瘤体积。年龄、卡诺夫斯基功能状态、神经外科手术切除以及替莫唑胺辅助放疗显示出生存优势。

讨论与结论

男性被诊断为恶性胶质瘤的年龄比女性小;然而,未观察到临床结果方面的优势。未观察到性别相关差异。

相似文献

1
Do clinical outcomes in individuals with malignant gliomas differ between sexes?恶性胶质瘤患者的临床结局在性别之间是否存在差异?
Brain Spine. 2024 Dec 24;5:104172. doi: 10.1016/j.bas.2024.104172. eCollection 2025.
2
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.神经外科医生大会关于化疗在成人新诊断的世界卫生组织二级弥漫性胶质瘤中作用的系统评价和循证指南:更新版
J Neurooncol. 2025 Jan;171(2):279-298. doi: 10.1007/s11060-024-04861-6. Epub 2024 Nov 20.
3
Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.WHO 分级 III 级胶质瘤切除范围的阈值:122 例术中 MRI 回顾性容积分析。
J Neurosurg. 2018 Jul;129(1):1-9. doi: 10.3171/2017.3.JNS162383. Epub 2017 Sep 8.
4
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.使用氨基酸正电子发射断层扫描(单光子发射计算机断层扫描)/计算机断层扫描/磁共振成像图像融合技术对复发性高级别胶质瘤进行再照射,以确定立体定向分割放射治疗的大体肿瘤体积。
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9. doi: 10.1016/j.ijrobp.2005.01.056.
5
Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.60 岁以上手术治疗的低级别弥漫性神经胶质瘤的分子特征和临床结局。
J Neurooncol. 2019 Jan;141(2):383-391. doi: 10.1007/s11060-018-03044-4. Epub 2018 Nov 29.
6
Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.接受调强放疗的高级别胶质瘤的临床和分子递归分区分析。
Am J Clin Oncol. 2019 Jan;42(1):27-35. doi: 10.1097/COC.0000000000000470.
7
An extent of resection threshold for seizure freedom in patients with low-grade gliomas.低级别胶质瘤患者无癫痫发作的切除范围阈值。
J Neurosurg. 2018 Apr;128(4):1084-1090. doi: 10.3171/2016.12.JNS161682. Epub 2017 May 26.
8
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.神经外科医师协会关于手术在弥漫性低级别胶质瘤患者管理中作用的系统评价及循证指南:更新版
J Neurooncol. 2025 Mar;172(1):99-152. doi: 10.1007/s11060-024-04871-4. Epub 2025 Jan 13.
9
Surgical, functional, and oncological considerations regarding awake resection for giant diffuse lower-grade glioma of more than 100 cm3.对于大于 100cm³的巨大弥漫性低级别胶质瘤,在手术、功能和肿瘤学方面的考虑因素。
J Neurosurg. 2023 Mar 24;139(4):934-943. doi: 10.3171/2023.2.JNS222755. Print 2023 Oct 1.
10
Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.复发性成人恶性胶质瘤的多模式管理:一项II期多药化疗研究结果及肿瘤减积手术分析
Neurosurgery. 1994 Sep;35(3):378-88; discussion 388. doi: 10.1227/00006123-199409000-00004.

本文引用的文献

1
[Gender inequality and mental health medicalization: Sociocultural determining factors from the analysis of expert perceptions].[性别不平等与精神健康医学化:基于专家观点分析的社会文化决定因素]
Aten Primaria. 2022 Jul;54(7):102378. doi: 10.1016/j.aprim.2022.102378. Epub 2022 May 30.
2
Sex Differences in Glioblastoma-Findings from the Swedish National Quality Registry for Primary Brain Tumors between 1999-2018.胶质母细胞瘤中的性别差异——1999年至2018年瑞典原发性脑肿瘤国家质量登记处的研究结果
J Clin Med. 2022 Jan 18;11(3):486. doi: 10.3390/jcm11030486.
3
Sex-Specific Differences in Glioblastoma.
胶质母细胞瘤的性别特异性差异。
Cells. 2021 Jul 14;10(7):1783. doi: 10.3390/cells10071783.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
5
Sex Differences in Time to Treat and Outcomes for Gliomas.胶质瘤治疗时间和预后的性别差异。
Front Oncol. 2021 Feb 19;11:630597. doi: 10.3389/fonc.2021.630597. eCollection 2021.
6
Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study.与胶质母细胞瘤长期生存相关的治疗和手术因素:一项国家癌症数据库研究。
Neurooncol Adv. 2020 Jun 4;2(Suppl 1):1-10. doi: 10.1093/noajnl/vdaa070. eCollection 2020 Jul.
7
Gliomas display distinct sex-based differential methylation patterns based on molecular subtype.胶质瘤根据分子亚型表现出明显的基于性别的差异甲基化模式。
Neurooncol Adv. 2020 Jan 8;2(1):vdaa002. doi: 10.1093/noajnl/vdaa002. eCollection 2020 Jan-Dec.
8
Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma.性别是胶质母细胞瘤的一个重要预后因素,但对非胶质母细胞瘤并非如此。
Neurooncol Pract. 2019 Dec;6(6):451-462. doi: 10.1093/nop/npz019. Epub 2019 May 18.
9
Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network.鉴定 p53 及其 X 染色体网络功能完整性中的癌症性别差异。
Nat Commun. 2019 Nov 26;10(1):5385. doi: 10.1038/s41467-019-13266-3.
10
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.美国 2012-2016 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100. doi: 10.1093/neuonc/noz150.